Table 1.
Patient characteristics
| Total (%) | |
|---|---|
| Gender | |
| Female | 57 (53.3) |
| Male | 50 (46.7) |
| Age at randomization | |
| Mean ± SD | 63.3 ± 10.1 |
| Median | 65 |
| Min-Max | 30-81 |
| Race | |
| White | 72 (67.3) |
| Asian | 26 (24.3) |
| Black | 5 (4.7) |
| American Indian | 1 (0.9) |
| UK/Not reported | 3 (2.8) |
| Ethnicity | |
| Hispanic | 7 (6.5) |
| Non-Hispanic | 100 (93.5) |
| Smoking status | |
| Never | 40 (37.4) |
| Currently | 6 (5.6) |
| Previously | 61 (57.0) |
| ECOG | |
| 0 | 52 (48.6) |
| 1 | 55 (51.4) |
| Stage | |
| IIIb | 10 (9.3) |
| IV | 97 (90.7) |
| Previous Treatment | |
| Surgery | 89 (84.0) |
| Chemo | 94 (87.8) |
| Radiation | 45 (42.1) |
| Clinic | |
| 01 | 97 (90.6) |
| 05 | 10 (9.4) |
| Histology | |
| Adenocarcinoma | 64 |
| NSCLC, NOS | 31 |
| Squamous | 11 |
| Unknown | 1 |
| EGFR mutation status | |
| Mutation positive | 26 |
| Wild type | 58 |
| Unknown | 23 |